Positioning biologics in the treatment of IBD: A practical guide – Which mechanism of action for whom?
The number of available biological therapies have doubled over the last 10 years and the arrival of novel molecules (interleukin 23p19 inhibitors) is ongoing alongside the development of small molecules. As a result of this vast landscape of treatment, positioning advanced therapies (according to cl...
Main Authors: | Pascal Juillerat, Maude Martinho Grueber, Roseline Ruetsch, Giulia Santi, Marianne Vuillèmoz, Pierre Michetti |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-01-01
|
Series: | Current Research in Pharmacology and Drug Discovery |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590257122000244 |
Similar Items
-
A Practical Guide to Therapeutic Drug Monitoring of Biologic Medications for Inflammatory Bowel Disease
by: Byron P. Vaughn
Published: (2021-10-01) -
Histological Hallmarks of Mucosal Healing in Inflammatory Bowel Diseases in the Era of Monoclonal Antibodies Therapy: New Insights and Perspectives
by: Gerardo Cazzato, et al.
Published: (2021-08-01) -
Inflammatory Bowel Diseases in Children: Modern Achievements in Diagnostics and Therapy
by: A. I. Khavkin, et al.
Published: (2024-01-01) -
Treatment of Ulcerative Colitis: Impact on Platelet Aggregation
by: Sasa Peric, et al.
Published: (2023-09-01) -
Impact of Functional Polymorphisms on Drug Survival of Biological Therapies in Patients with Moderate-to-Severe Psoriasis
by: Cristina Membrive-Jiménez, et al.
Published: (2023-05-01)